Back to Search
CARLOS SANTOS-GALLEGO, MD, PHD
MD, PHD
Research Study Specialist
NPI: 1790479848Individual
Specialties, Licenses & Credentials
Research Study SpecialistPrimary
Specialist — Research Study
Code: 1744R1102X
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (5)
HDL-cholesterol: is it really good? Differences between apoA-I and HDL.
PMID 18547543·Biochem Pharmacol·2008
6-review
Quantification of serial changes in plaque burden using multi-detector computed tomography in experimental atherosclerosis.
PMID 18466906·Atherosclerosis·2009
7-preclinical
Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis.
PMID 18342230·J Am Coll Cardiol·2008
7-preclinical
Pioglitazone induces vascular smooth muscle cell apoptosis through a peroxisome proliferator-activated receptor-gamma, transforming growth factor-beta1, and a Smad2-dependent mechanism.
PMID 15734860·Diabetes·2005
7-preclinical
Acetylsalicylic acid inhibits cell proliferation by involving transforming growth factor-beta.
PMID 12566377·Circulation·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1428 MADISON AVE BLDG 6TH
NEW YORK, NY 10029 - Phone
- (212) 241-8484
Quick Facts
- NPI
- 1790479848
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 5
Are you this provider?
Claim Your Profile